Legal & General Group
TYRA icon

Legal & General Group’s Tyra Biosciences TYRA Stock Holding History

Legal & General Group’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$365K Buy
9,537
+7,170
+303% +$232K ﹤0.01% 2441
2025
Q4 		$62.2K Buy
2,367
+175
+8% +$3.21K ﹤0.01% 2689
2025
Q3 		$30.7K Hold
2,192
– – ﹤0.01% 2882
2025
Q2 		$21K Sell
2,192
-7,069
-76% -$67.2K ﹤0.01% 2981
2025
Q1 		$86.1K Sell
9,261
-79
-0.8% -$1.02K ﹤0.01% 2680
2024
Q4 		$130K Hold
9,340
– – ﹤0.01% 2701
2024
Q3 		$220K Buy
9,340
+7,091
+315% +$149K ﹤0.01% 2665
2024
Q2 		$36K Buy
2,249
+984
+78% +$16.9K ﹤0.01% 2841
2024
Q1 		$20.7K Hold
1,265
– – ﹤0.01% 2946
2023
Q4 		$17.6K Hold
1,265
– – ﹤0.01% 3078
2023
Q3 		$17.6K Sell
1,265
-267
-17% -$3.96K ﹤0.01% 3086
2023
Q2 		$26.1K Buy
1,532
+127
+9% +$1.84K ﹤0.01% 3000
2023
Q1 		$22.6K Hold
1,405
– – ﹤0.01% 3036
2022
Q4 		$10.7K Hold
1,405
– – ﹤0.01% 3258
2022
Q3 		$12K Buy
1,405
+444
+46% +$4.06K ﹤0.01% 3312
2022
Q2 		$7K Sell
961
-165
-15% -$1.31K ﹤0.01% 3419
2022
Q1 		$12K Hold
1,126
– – ﹤0.01% 3369
2021
Q4 		$16K Buy
+1,126
New +$22.4K ﹤0.01% 3351

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Legal & General Group's TYRA Position: Q1 2026 in Review

Legal & General Group increased its Tyra Biosciences (TYRA) stake by 303% in Q1 2026, buying an estimated $232K and bringing the position to 9,537 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #2441.

Legal & General Group first reported a position in TYRA in Q4 2021 and has held it in 18 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Legal & General Group held 9,537 shares of Tyra Biosciences worth $365K as of Q1 2026.
  • Legal & General Group bought 7,170 Tyra Biosciences shares in Q1 2026, an estimated $232K.
  • Tyra Biosciences made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2441 holding.
  • Legal & General Group first reported a position in Tyra Biosciences in Q4 2021 and has held it in 18 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.